Crinetics Pharmaceuticals, Inc. dropped from S&P TMI ...
Crinetics Pharmaceuticals, Inc. (NasdaqGS:CRNX) dropped from S&P Pharmaceuticals Select Industry Index ...
“Crying,” or “tearing up,” is not just one thing. There are in fact three types of tears, two of which are rather uninteresting: basal tears that lubricate and protect the eye, and reflex tears that ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the successful completion of the acquisition of Crinetics ...
Zacks Investment Research on MSN
Neurocrine's Crenessity gains ground in CAH: How far can sales go?
Neurocrine Biosciences NBIX continues to rely heavily on its blockbuster VMAT2 inhibitor, Ingrezza, for top-line growth.
Lundbeck has secured orphan designation from the European Commission for asedebart, its investigational anti‑ACTH monoclonal ...
The European Commission (EC) has granted orphan designation to Lundbeck's investigational monoclonal antibody asedebart (Lu ...
The European Commission has granted orphan designation for asedebart (Lu AG13909), Lundbeck's novel investigational anti-ACTH monoclonal antibody, for the treatment of Cushing's syndrome of ...
The NHS has outlined several additional symptoms of the condition, which is a rare disorder where the adrenal glands situated above your kidneys fail to function correctly. Addison's disease can ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results